[Federal Register Volume 84, Number 164 (Friday, August 23, 2019)]
[Notices]
[Pages 44308-44309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18211]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-1154; Docket No. CDC-2019-0072]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on a proposed and/
or continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on ``Generic
Clearance for CDC/ATSDR Formative Research and Tool Development''. This
information collection request is designed to allow CDC to conduct
formative research information collection activities used to inform
aspects of surveillance, communications, health promotion, and research
project development.
DATES: Written comments must be received on or before October 22, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0072 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who respond, including through the use of automated, electronic,
mechanical, or other technilogical collection techniques or other forms
of information technology; e.g., permitting electronic submissions of
responses.
5. Assess information costs.
Proposed Project
Generic Clearance for CDC/ATSDR Formative Research and Tool
Development--Extension--Office of Science (OS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) requests
approval for an extension of a generic clearance for CDC/ATSDR
Formative Research and Tool Development. This information collection
request is designed to allow CDC to conduct formative research
information collection activities used to inform many aspects of
surveillance, communications, health promotion, and research project
development at CDC. Formative research is the basis for developing
effective strategies including communication channels, for influencing
behavior change. It helps researchers identify and understand the
characteristics--interests, behaviors and needs--of target populations
that influence their decisions and actions.
Formative research is integral in developing programs, as well as
improving existing and ongoing programs. Formative research looks at
the community in which a public health intervention is being or will be
implemented and helps the project staff understand the interests,
attributes and needs of different populations and persons in that
community. Formative research occurs before a program is designed and
implemented, or while a program is being conducted.
At CDC, formative research is necessary for developing new programs
or adapting programs that deal with the complexity of behaviors, social
context, cultural identities, and health care that underlie the
epidemiology of diseases and conditions in the U.S. CDC conducts
formative research to develop public-sensitive communication messages
and user friendly tools prior to developing or recommending
interventions, or care. Sometimes these studies are entirely behavioral
but most often they are cycles of interviews and focus groups designed
to inform the development of a product.
[[Page 44309]]
Products from these formative research studies will be used for
prevention of disease. Findings from these studies may also be
presented as evidence to disease-specific National Advisory Committees,
to support revisions to recommended prevention and intervention
methods, as well as new recommendations.
Much of CDC's health communication takes place within campaigns
that have fairly lengthy planning periods-- timeframes that accommodate
the standard Federal process for approving data collections. Short term
qualitative interviewing and cognitive research techniques have
previously proven invaluable in the development of scientifically valid
and population-appropriate methods, interventions, and instruments.
This request includes studies investigating the utility and
acceptability of proposed sampling and recruitment methods,
intervention contents and delivery, questionnaire domains, individual
questions, and interactions with project staff or electronic data
collection equipment. These activities will also provide information
about how respondents answer questions and ways in which question
response bias and error can be reduced.
This request also includes collection of information from public
health programs to assess needs related to initiation of a new program
activity or expansion or changes in scope or implementation of existing
program activities to adapt them to current needs. The information
collected will be used to advise programs and provide capacity-building
assistance tailored to identify needs.
Overall, these development activities are intended to provide
information that will increase the success of the surveillance or
research projects through increasing response rates and decreasing
response error, thereby decreasing future data collection burden to the
public. The studies that will be covered under this request will
include one or more of the following investigational modalities: (1)
Structured and qualitative interviewing for surveillance, research,
interventions and material development, (2) cognitive interviewing for
development of specific data collection instruments, (3) methodological
research, (4) usability testing of technology-based instruments and
materials, (5) field testing of new methodologies and materials, (6)
investigation of mental models for health decision-making to inform
health communication messages, and (7) organizational needs assessments
to support development of capacity. Respondents who will participate in
individual and group interviews (qualitative, cognitive, and computer
assisted development activities) are selected purposively from those
who respond to recruitment advertisements.
In addition to utilizing advertisements for recruitment,
respondents who will participate in research on survey methods may be
selected purposively or systematically from within an ongoing
surveillance or research project. Participation of respondents is
voluntary. There is no cost to participants other than their time. The
total estimated annual burden is 20,000 hours.
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours Total response
respondents respondent per response burden (hrs.)
----------------------------------------------------------------------------------------------------------------
General public and health care Screener........ 10,000 1 15/60 2,500
providers.
Interview....... 5,000 1 1 5,000
Focus group 5,000 1 2 10,000
interview.
Survey.......... 5,000 1 30/60 2,500
Total..................... ................ 25,000 .............. .............. 20,000
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-18211 Filed 8-22-19; 8:45 am]
BILLING CODE 4163-18-P